Adem KÜÇÜK, Ayça TUZCU, Göksel TUZCU, Ali Uğur USLU, Ahmet OMMA, Rabia Aydoğan BAYKARA

A novel marker relationship between carotid intima–media thickness and disease activity score-28 in patients with rheumatoid arthritis: human endothelial cell-specific molecule-1

Background/aim: Human endothelial cell-specific molecule-1 (endocan) is a marker of vascular endothelial dysfunction that may beused in the evaluation of inflammatory-associated atherosclerotic lesions. Endocan may be a marker for the evaluation of atherosclerosisand disease activity in rheumatoid arthritis (RA) patients.Materials and methods: We included 39 RA patients assessed according to the American College of Rheumatology/European LeagueAgainst Rheumatology 2010 diagnostic criteria and recruited 30 age- and sex-matching healthy subjects for the control group.Results: Endocan values were 14.11 ± 3.27 for the RA patients and 12.10 ± 2.92 for the controls. The endocan values of the patientswere significantly higher than those of the control group (P = 0.009). In the correlation analysis, endocan showed a significantly positivecorrelation with disease activity score-28 (r = 0.386, P = 0.029) and carotid intima–media thickness (cIMT) (r = 0.419, P = 0.008). Linearregression analysis revealed that there was an independent relationship between endocan and cIMT (P = 0.029).Conclusion: Endocan can be a marker for early atherosclerosis and disease activity in RA patients.

PDF

___

1. Sanmartí R, Ruiz-Esquide V, Hernández MV. Rheumatoid arthritis: a clinical overview of new diagnostic and treatment approaches. Current Topics in Medicinal Chemistry 2013; 13 (6): 698-704.
2. Karimifar M, Salesi M, Farajzadegan Z. The association of antiCCP1 antibodies with disease activity score 28 (DAS-28) in rheumatoid arthritis. Advanced Biomedical Research 2012; 1: 30.
3. Assayag D, Lee JS, King TE Jr. Rheumatoid arthritis associated interstitial lung disease: a review. Medicina (Buenos Aires) 2014; 74 (2): 158-165.
4. Lauper K, Gabay C. Cardiovascular risk in patients with rheumatoid arthritis. Seminars in Immunopathology 2017; 39 (4): 447-445.
5. Balta S, Ozturk C. The relation between CD40 ligand and coronary artery disease. Cardiology 2015; 131: 107-108.
6. Sarrazin S, Adam E, Lyon M, Depontieu F, Motte V et al. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochimica et Biophysica Acta 2006; 1765: 25- 37.
7. Kali A, Shetty KSR. Endocan: a novel circulating proteoglycan. Indian Journal of Pharmacology 2014; 46: 579-583.
8. Altintas N, Mutlu LC, Akkoyun DC, Aydin M, Bilir B et al. Effect of CPAP on new endothelial dysfunction marker, endocan, in people with obstructive sleep apnea. Angiology 2016; 67 (4): 364-374.
9. Uslu AU, Kucuk A, Icli A, Cure E, Sakiz D et al. Plasma atherogenic index is an independent indicator of subclinical atherosclerosis in systemic lupus erythematosus. Eurasian Journal of Medicine 2017; 49 (3): 193-197.
10. Balta I, Balta S, Koryurek OM, Demirkol S, Mikhailidis DP et al. Serum endocan levels as a marker of disease activity in patients with Behçet disease. Journal of the American Academy of Dermatology 2014; 70: 291-296.
11. Icli A, Cure E, Cure MC, Uslu AU, Balta S et al. Endocan levels and subclinical atherosclerosis in patients with systemic lupus erythematosus. Angiology 2016; 67 (8): 749-755.
12. Kedar MP, Acharya RV, Prakashini K. Performance of the 2010 American College of Rheumatology/European League against Rheumatism (ACR/EULAR) criteria for classification of rheumatoid arthritis in an Indian population: an observational study in a single centre. Indian Journal of Medical Research 2016; 144 (2): 288-292.
13. Van Gestel AM, Haagsma CJ, van Riel PLCM. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis & Rheumatology 1998; 41 (10): 1845-1850.
14. Shenavar Masooleh I, Zayeni H, Haji-Abbasi A, Azarpira M, Hadian A et al. Cardiac involvement in rheumatoid arthritis: a cross-sectional study in Iran. Indian Heart Journal 2016; 68 (3): 332-335.
15. Purcarea A, Sovaila S, Gheorghe A, Udrea G, Stoica V. Cardiovascular disease risk scores in the current practice: which to use in rheumatoid arthritis? Journal of Medicine and Life 2014; 7 (4): 461-467.
16. Skeoch S, Bruce IN. Atherosclerosis in rheumatoid arthritis: is it all about inflammation? Nature Reviews Rheumatology 2015; 11 (7): 390-400.
17. Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 2008; 196 (2): 756-763.
18. Uslu AU, Kucuk A, Balta S, Ozturk C, Arslan S et al. The relation between ischemia modified albumin levels and carotid intima media thickness in patients with rheumatoid arthritis. International Journal of Rheumatic Diseases 2019; 22 (1): 32-37.
19. Tutoğlu A, Boyaci A, Boyaci N, Kaya Z, Aridici R et al. Is there any relationship between joint destruction and carotid intimamedia thickness in patients with rheumatoid arthritis? Journal of Physical Therapy Science 2014; 26 (7): 1093-1096.
20. Vázquez-Del Mercado M, Nuñez-Atahualpa L, FigueroaSánchez M, Gómez-Bañuelos E, Rocha-Muñoz AD et al. Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-α, and C-reactive protein are associated with increased carotid intima-media thickness: a cross-sectional analysis of a cohort of rheumatoid arthritis patients without cardiovascular risk factors. BioMed Research International 2015; 2015: 342649.
21. Verma I, Syngle A, Krishan P. Predictors of endothelial dysfunction and atherosclerosis in rheumatoid arthritis in Indian population. Indian Heart Journal 2017; 69 (2): 200-206.
22. Libby P. Inflammation in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2012; 32 (9): 2045-2051.
23. Balta S, Mikhailidis DP, Demirkol S, Ozturk C, Celik T, Iyisoy A. Endocan: a novel inflammatory indicator in cardiovascular disease? Atherosclerosis 2015; 243 (1): 339-343.
24. Ozalper V, Kara M, Tanoglu A, Cetindagli I, Ozturker C et al. Evaluation of endothelial dysfunction in patients with familial Mediterranean fever: the relationship between the levels of asymmetric dimethylarginine and endocan with carotid intima-media thickness and endothelium-dependent vasodilation. Clinical Rheumatology 2017; 36 (9): 2071-2077.